NCT06941480 2026-02-19
A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate
Memorial Sloan Kettering Cancer Center
Phase 1 Not yet recruiting
Clinical Trials
25 trialsNCT07416825 2026-02-18
Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19
Institute of Oncology Ljubljana
Phase NA Completed
NCT04018053 2026-01-27
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
Brigham and Women's Hospital
Phase EARLY_PHASE1 Active not recruiting
NCT06122610 2026-01-15
Using Novel Imaging to More Safely Treat Neuroendocrine Tumors
University of Wisconsin, Madison
Phase 1 Recruiting
NCT03851237 2025-12-23
CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
Washington University School of Medicine
Phase 1 Completed
NCT07272772 2025-12-09
Colon Cancer Diagnosis With FAPI-PET Imaging
Turku University Hospital
Phase 2/3 Recruiting
NCT03647358 2025-12-02
Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT06062745 2025-11-05
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
Brigham and Women's Hospital
Phase 1 Recruiting
NCT06479187 2025-11-05
PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer
Brigham and Women's Hospital
Phase 4 Active not recruiting
NCT05513027 2025-09-17
Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion Detection
Washington University School of Medicine
Phase NA Active not recruiting
NCT01920737 2025-09-16
A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT02608216 2025-09-03
[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer
University of Pennsylvania
Phase 1 Active not recruiting
NCT06055790 2025-09-03
Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis
University of Arizona
Phase 2 Recruiting
NCT04468841 2025-08-19
Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT06863233 2025-08-12
A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT03314636 2025-08-08
CONPET
Oslo University Hospital
Phase 2 Active not recruiting
NCT01879657 2025-08-06
68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)
Radio Isotope Therapy of America
Phase NA Completed
NCT04518748 2025-08-05
Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.
University of Michigan Rogel Cancer Center
Phase 1 Recruiting
NCT07098598 2025-08-01
Pancreatic Cancer Diagnosis With FAPI-PET Imaging
Turku University Hospital
Phase 2/3 Recruiting
NCT05034146 2025-06-05
68Ga-FAPI PET/CT in Malignant Tumors
Zhongnan Hospital
Phase NA Recruiting
NCT04566978 2025-04-23
89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL)
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Completed
NCT06067503 2025-04-22
Biomarkers to Detect Endocrine Therapy Resistance
University of Wisconsin, Madison
Phase 2 Recruiting
NCT03824535 2025-04-09
18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
Stanford University
Phase 2 Completed
NCT01604512 2025-04-08
A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT06914427 2025-04-06
PET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique
Xijing Hospital
Phase NA Not yet recruiting